NTLAIntellia Therapeutics, Inc.vs its industry peers
A metric-by-metric comparison of Intellia Therapeutics, Inc. against ARK Innovation ETF holdings — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NTLAThis | $1.7B#14 | — | 2.4x#2 | 25.8x#11 | 16.9%#10 | 20.5%#8 | -651.7%#13 | -56.7%#14 | — | — | — | — |
| TSLA | $1.58T#1 | 438.6x#6 | 17.7x#12 | 16.6x#5 | -2.9%#13 | -46.1%#11 | 4.6%#6 | 4.3%#6 | 4.3%#4 | 5#2 | -9.3%#4 | — |
| TEM | $13M#15 | — | 0.0x#1 | 0.0x#1 | 83.4%#3 | 65.3%#5 | -19.9%#8 | -55.1%#13 | — | — | -16.3%#6 | — |
| SPCX | $986.8B#2 | — | 5.6x#7 | — | — | — | — | 0.0%#7 | — | — | — | — |
| CRSP | $5.0B#12 | — | 2.8x#5 | 1415.8x#14 | -90.6%#14 | -58.8%#13 | -18933.6%#14 | -33.3%#12 | -32.6%#5 | — | -15.9%#5 | — |
| SHOP | $204.6B#5 | 106.4x#3 | 16.1x#11 | 17.7x#7 | 30.1%#8 | -39.0%#10 | 12.7%#4 | 9.7%#3 | — | — | -9.3%#3 | — |
| COIN | $37.9B#7 | — | 2.7x#4 | 5.3x#2 | 9.4%#11 | -50.0%#12 | 20.0%#3 | 9.3%#4 | 9.9%#2 | — | — | — |
| AMD | $824.7B#3 | 129.5x#4 | 12.3x#10 | 23.8x#9 | 34.3%#7 | 164.2%#2 | 10.7%#5 | 6.4%#5 | 5.7%#3 | 8#1 | 98.2%#2 | — |
| CRCL | $17.9B#9 | 14.5x#1 | 5.1x#6 | 162.6x#13 | 624.0%#1 | -144.7%#14 | -87.8%#11 | -2.0%#8 | — | — | -40.9%#8 | — |
| HOOD | $76.4B#6 | 39.2x#2 | 8.9x#8 | 17.1x#6 | 51.6%#5 | 33.5%#7 | 47.1%#1 | 22.0%#1 | 34.9%#1 | — | -38.4%#7 | — |
| TWST | $9.6B#10 | — | 21.5x#13 | 25.4x#10 | 20.3%#9 | 62.8%#6 | -36.2%#10 | -17.4%#11 | -41.4%#7 | — | — | — |
| TXG | $9.0B#11 | — | 10.8x#9 | 13.9x#4 | 5.2%#12 | 76.2%#4 | -9.5%#7 | -5.3%#9 | — | — | 464.5%#1 | — |
| PLTR | $442.4B#4 | 157.4x#5 | 45.3x#14 | 98.8x#12 | 56.2%#4 | 251.6%#1 | 31.6%#2 | 16.6%#2 | — | — | — | — |
| BEAM | $2.8B#13 | — | 2.6x#3 | 20.1x#8 | 120.0%#2 | 78.8%#3 | -274.6%#12 | -7.5%#10 | -40.5%#6 | — | — | — |
| RBLX | $30.8B#8 | — | — | 6.3x#3 | 35.8%#6 | -13.9%#9 | -25.2%#9 | — | — | — | — | — |
Peer set: top holdings of ARKK (ARK Innovation ETF), the indexed fund holding this stock at its highest weight — a fund manager's grouping, not Tickwind's judgement. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-11-01.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice